An in vitro model was developed to replicate hepatitis E virus (HEV) i
n normal primary cynomolgus macaque hepatocytes using a hormonally def
ined, serum-free medium formulation. Primary hepatocytes were infected
in tissue culture following isolation by collagenase treatment of liv
er wedge biopsy material. Viral replication was monitored by a highly
strand-specific reverse transcription-polymerase chain reaction (RT-PC
R) assay, which could detect the positive-and negative-strands of HEV
RNA independently in a sensitive and specific manner. Several infectio
us HEV (Burma strain) inocula were titered by this RT-PCR assay, and a
minimum effective infectious dose was determined. Appearance of newly
replicated virus was demonstrated by detection of both strands of HEV
RNA in experimentally infected hepatocytes as well as the genomic pos
itive-strand viral RNA in the culture medium. Infectivity of the virus
particles present in the media was confirmed by serial passage and re
plication of the virus in culture. Using this in vitro infection syste
m, a neutralization assay was developed to assess the ability of anti-
HN antibodies to block virus infection of liver cells. Results present
ed in this report represent the first in vitro demonstration of a neut
ralizing anti-HEV antibody directed against the ORF2-encoded putative
capsid protein. (C) 1997 Academic Press.